Optiver Holding
VNDA icon

Optiver Holding’s Vanda Pharmaceuticals VNDA Stock Holding History

Optiver Holding’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
18,089
-2,247
-11% -$14.7K ﹤0.01% 1004
2026
Q1 		$141K Buy
20,336
+19,860
+4,172% +$153K ﹤0.01% 855
2025
Q4 		$4.2K Hold
476
– – ﹤0.01% 1494
2025
Q3 		$2.38K Buy
+476
New +$2.2K ﹤0.01% 2316

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's VNDA Position: Q2 2026 in Review

Optiver Holding reduced its Vanda Pharmaceuticals (VNDA) stake by 11% in Q2 2026, selling an estimated $14.7K and leaving 18,089 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1004.

Optiver Holding first reported a position in VNDA in Q3 2025 and has held it in 4 quarters since. The position peaked at $141K in Q1 2026. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Optiver Holding held 18,089 shares of Vanda Pharmaceuticals worth $111K as of Q2 2026.
  • Optiver Holding sold 2,247 Vanda Pharmaceuticals shares in Q2 2026, an estimated $14.7K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1004 holding.
  • Optiver Holding first reported a position in Vanda Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Vanda Pharmaceuticals position peaked at $141K in Q1 2026.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.